Logo

Fisher Subsidiary Abgene Licenses ABI Tech to Offer PCR-related Products, Develop Its Own

Jun 29, 2006

NEW YORK, June 29 (GenomeWeb News) - Applied Biosystems has granted Fisher Biosciences licenses to allow its subsidiary, Abgene, to offer several PCR and real-time PCR products, the companies said today.

 

Under the agreement, Abgene will be allowed to offer PCR and real-time PCR reagents and kits, and has the right to develop new real-time PCR products and technologies, the companies said.

Breaking News
The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.